Literature DB >> 18437278

Eye movement deficits in schizophrenia: investigation of a genetically homogenous Icelandic sample.

H Magnus Haraldsson1, Ulrich Ettinger, Brynja B Magnusdottir, Thordur Sigmundsson, Engilbert Sigurdsson, Hannes Petursson.   

Abstract

BACKGROUND: Deficits in antisaccade (AS) and smooth pursuit eye movements (SPEM) are promising endophenotypes in genetic studies of schizophrenia. The Icelandic population lends itself ideally to genetic studies due to its ethnic homogeneity and well-documented genealogy. The primary aim of this study was to assess AS and SPEM performance in a large Icelandic sample. Additional aims were to investigate the relationship between AS and SPEM task performance and to assess internal consistency, within-session performance changes and effects of SPEM target velocity on performance.
METHOD: Patients with schizophrenia (N = 118) and healthy controls (N = 109) matched for age and gender underwent infrared oculographic assessment of AS and SPEM (at target velocities of 12 degrees , 24 degrees and 36 degrees /s).
RESULTS: On the AS task patients displayed significantly more reflexive errors, longer latency, increased intra-individual latency variability, and reduced amplitude gain compared to controls. On the SPEM task, patients had significantly lower velocity gain and more frequent saccades during pursuit at all velocities, but group differences in velocity gain increased with increasing target velocity. Internal consistency of performance was high for all variables in both groups (Cronbach's alpha >0.77 for AS and >0.85 for SPEM) except for AS spatial error in patients (alpha = 0.38). A moderate association was found between AS and SPEM performance. By and large, patients and controls showed similar patterns of systematic within-session performance changes.
CONCLUSIONS: Our findings confirm the existence of robust eye movement deficits in schizophrenia in a large sample. These measures may be studied as endophenotypes in future studies of potential schizophrenia risk genotypes in the genetically homogenous Icelandic population.

Entities:  

Mesh:

Year:  2008        PMID: 18437278     DOI: 10.1007/s00406-008-0806-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  78 in total

1.  Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives. A parametric study of the effects of increasing inhibitory load.

Authors:  C E Curtis; M E Calkins; W G Iacono
Journal:  Exp Brain Res       Date:  2001-03       Impact factor: 1.972

2.  Error rate on the antisaccade task: heritability and developmental change in performance among preadolescent and late-adolescent female twin youth.

Authors:  Stephen M Malone; William G Iacono
Journal:  Psychophysiology       Date:  2002-09       Impact factor: 4.016

3.  Time-limit tests: estimating their reliability and degree of speeding.

Authors:  L J CRONBACH; W G WARRINGTON
Journal:  Psychometrika       Date:  1951-06       Impact factor: 2.500

4.  Different extraretinal neuronal mechanisms of smooth pursuit eye movements in schizophrenia: An fMRI study.

Authors:  Matthias Nagel; Andreas Sprenger; Matthias Nitschke; Silke Zapf; Wolfgang Heide; Ferdinand Binkofski; Rebekka Lencer
Journal:  Neuroimage       Date:  2006-10-02       Impact factor: 6.556

5.  Saccadic eye movements in schizophrenic patients.

Authors:  B Karoumi; J Ventre-Dominey; A Vighetto; J Dalery; T d'Amato
Journal:  Psychiatry Res       Date:  1998-01-16       Impact factor: 3.222

Review 6.  Behavioral and brain imaging studies of saccadic performance in schizophrenia.

Authors:  J E McDowell; B A Clementz
Journal:  Biol Psychol       Date:  2001 Jul-Aug       Impact factor: 3.251

7.  Smooth pursuit and saccadic abnormalities in first-episode schizophrenia.

Authors:  S B Hutton; T J Crawford; B K Puri; L J Duncan; M Chapman; C Kennard; T R Barnes; E M Joyce
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

8.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  Maladaptive anticipatory saccades in schizophrenia.

Authors:  D W Hommer; T Clem; R Litman; D Pickar
Journal:  Biol Psychiatry       Date:  1991-10-15       Impact factor: 13.382

View more
  11 in total

1.  Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study.

Authors:  Allen D Radant; Dorcas J Dobie; Monica E Calkins; Ann Olincy; David L Braff; Kristin S Cadenhead; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Gregory A Light; Sean P Meichle; Steve P Millard; Jim Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Ming T Tsuang; Bruce I Turetsky; Debby W Tsuang
Journal:  Psychophysiology       Date:  2010-04-05       Impact factor: 4.016

2.  Enhanced top-down control during pursuit eye tracking in schizophrenia.

Authors:  Andreas Sprenger; Peter Trillenberg; Matthias Nagel; John A Sweeney; Rebekka Lencer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

3.  Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk.

Authors:  Lihua Xu; Dan Zhang; Yuou Xie; Xiaochen Tang; Yegang Hu; Xu Liu; Guisen Wu; Zhenying Qian; Yingying Tang; Zhi Liu; Tao Chen; HaiChun Liu; Tianhong Zhang; Jijun Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-20       Impact factor: 5.760

4.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

5.  Effects of ketamine on brain function during smooth pursuit eye movements.

Authors:  M Steffens; B Becker; C Neumann; A M Kasparbauer; I Meyhöfer; B Weber; M A Mehta; R Hurlemann; U Ettinger
Journal:  Hum Brain Mapp       Date:  2016-11       Impact factor: 5.038

6.  Neuregulin-1 genotypes and eye movements in schizophrenia.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Andres Ingason; Samuel B Hutton; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-03       Impact factor: 5.270

7.  Neural mechanisms of smooth pursuit eye movements in schizotypy.

Authors:  Inga Meyhöfer; Maria Steffens; Anna Kasparbauer; Phillip Grant; Bernd Weber; Ulrich Ettinger
Journal:  Hum Brain Mapp       Date:  2014-09-05       Impact factor: 5.038

8.  Exploratory eye movement dysfunction as a discriminator for schizophrenia : a large sample study using a newly developed digital computerized system.

Authors:  Masahiro Suzuki; Sakae Takahashi; Eisuke Matsushima; Masahiko Tsunoda; Masayoshi Kurachi; Takashi Okada; Takuji Hayashi; Yohei Ishii; Kiichiro Morita; Hisao Maeda; Seiji Katayama; Ryuzou Kawahara; Tatsui Otsuka; Yoshio Hirayasu; Mizuho Sekine; Yoshiro Okubo; Mai Motoshita; Katsuya Ohta; Makoto Uchiyama; Takuya Kojima
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-01-22       Impact factor: 5.270

9.  Eye movements in patients in early psychosis with and without a history of cannabis use.

Authors:  Musa Basseer Sami; Luciano Annibale; Aisling O'Neill; Tracy Collier; Chidimma Onyejiaka; Savitha Eranti; Debasis Das; Marlene Kelbrick; Philip McGuire; Steve C R Williams; Anas Rana; Ulrich Ettinger; Sagnik Bhattacharyya
Journal:  NPJ Schizophr       Date:  2021-05-12

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.